Weekly Tech+Bio Highlights #63: Quantum vs. AI Small Molecule Design

FDA’s pathway for custom gene editing, UK’s non-animal testing roadmap, OpenAI leads a biosecurity seed, 100x mRNA delivery & over $1B in fresh life sciences VC funds

Hi! This is BiopharmaTrend’s weekly newsletter, Where Tech Meets Bio, where we explore technologies, breakthroughs, and cutting-edge companies.

If this newsletter is in your inbox, it’s because you subscribed, or someone thought you might enjoy it. In either case, you can subscribe directly by clicking this button: